ENDS Respiratory System: Difference between revisions

Marked this version for translation
suggestions
(One intermediate revision by the same user not shown)
Line 231: Line 231:
=2nd Hand Vapor= <!--T:56-->
=2nd Hand Vapor= <!--T:56-->


===2022: [https://link.springer.com/article/10.1007/s11739-022-03061-2 Computational modeling method to estimate secondhand exposure potential from exhalations during e-vapor product use under various real-world scenarios]===
*Acetaldehyde and acrolein were not detectable after use of any of the test products.
*When these data were used as inputs to a computational room air level and non-user intake model, the ambient concentrations of exhaled nicotine and formaldehyde predicted that non-user intakes were substantially reduced for test product use compared to conventional cigarette use.
*Collectively, the results predict that room air levels and exposure of the selected analytes to non-users were relatively low and several-fold below regulatory PELs and AIHA limit under the modeled space and use conditions.
*...room air levels of nicotine, formaldehyde, acrolein, and acetaldehyde levels were significantly below OSHA PELs or American Industrial Hygiene Association (AIHA) limit...




Line 273: Line 279:
Non-cancer risk analysis revealed “No Significant Risk” of harm to human health for vapor samples from e-liquids.
Non-cancer risk analysis revealed “No Significant Risk” of harm to human health for vapor samples from e-liquids.
With regard to cancer risk analysis, no vapor sample from e-liquids exceeded the risk limit for either children or adults.
With regard to cancer risk analysis, no vapor sample from e-liquids exceeded the risk limit for either children or adults.
 
<br>
 


=PAGE EDITORS - Please add Studies, Surveys, Papers in this format to keep page organized= <!--T:67-->
=PAGE EDITORS - Please add Studies, Surveys, Papers in this format to keep page organized= <!--T:67-->
Line 290: Line 295:


<!--T:69-->
<!--T:69-->
https://pubs.acs.org/doi/10.1021/acs.chemrestox.1c00253
===https://pubs.acs.org/doi/10.1021/acs.chemrestox.1c00253===
 
===2022: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526897/ Association of tobacco product use with chronic obstructive pulmonary disease (COPD) prevalence and incidence in Waves 1 through 5 (2013–2019) of the Population Assessment of Tobacco and Health (PATH) Study]===


=More Information= <!--T:70-->
=More Information= <!--T:70-->